Lawrence Erik Kurzius
Chairman, President & CEO at McCormick & Company Incorporated
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 12 years
- Director since
- 2023
12 years of board service in total across 4 boards, counting each seat separately. Longest: Elanco Animal Health Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lamb Weston Holdings Inc. September 16, 202694.1%
-
Elanco Animal Health Incorporated May 21, 202694.7%
-
The Cooper Companies Inc. April 7, 202695.9%
-
Lamb Weston Holdings Inc. September 25, 202597.6%
-
The Cooper Companies Inc. April 2, 202597.0%
-
McCormick & Company Incorporated March 27, 202497.4%
-
The Cooper Companies Inc. March 19, 202491.1%
-
McCormick & Company Incorporated March 29, 202398.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2026 | Lamb Weston Holdings Inc. | Grant or award | +5,458 | — | — |
| Sep 16, 2026 | The Cooper Companies Inc. | Open-market purchase | +10,000 | $54.93 | $549,300 |
| Sep 14, 2026 | The Cooper Companies Inc. | Open-market purchase | +10,000 | $53.92 | $539,200 |
| Aug 20, 2026 | Elanco Animal Health Incorporated | Open-market purchase | +40,000 | $23.40 | $936,000 |
| Aug 10, 2026 | McCormick & Company Incorporated | Option exercise | +205,538 | $49.03 | $10,077,528 |
| Aug 10, 2026 | McCormick & Company Incorporated | Open-market sale | −205,538 | $52.69 | $10,829,797 |
| May 21, 2026 | Elanco Animal Health Incorporated | Grant or award | +4,678 | — | — |
| May 21, 2026 | Elanco Animal Health Incorporated | Grant or award | +12,196 | — | — |
| Apr 1, 2026 | The Cooper Companies Inc. | Option exercise | +3,322 | — | — |
| Feb 12, 2026 | McCormick & Company Incorporated | Option exercise | +50,000 | $49.03 | $2,451,500 |
| Feb 12, 2026 | McCormick & Company Incorporated | Open-market sale | −50,000 | $71.63 | $3,581,500 |
| Jan 19, 2026 | McCormick & Company Incorporated | Grant or award | +50,230 | — | — |
| Jan 13, 2026 | McCormick & Company Incorporated | Option exercise | +50,000 | $49.96 | $2,498,000 |
| Jan 13, 2026 | McCormick & Company Incorporated | Open-market sale | −50,000 | $67.43 | $3,371,500 |
| Dec 17, 2025 | The Cooper Companies Inc. | Open-market purchase | +2,000 | $82.50 | $165,000 |
Questions about Lawrence Erik Kurzius
What boards is Lawrence Erik Kurzius on?
Lawrence Erik Kurzius sits on the boards of Elanco Animal Health Incorporated, Lamb Weston Holdings Inc., McCormick & Company Incorporated and The Cooper Companies Inc.
What company is Lawrence Erik Kurzius the CEO of?
Lawrence Erik Kurzius is Chairman, President & CEO of McCormick & Company Incorporated.
How long has Lawrence Erik Kurzius served on boards?
Our records show at least 12 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.